Although there is no general consensus regarding gene mutation and prognosis association, several clinical trials demonstrated that D, particularly, KIT exon 11 codon 557-558 D (K11-557/558D) is linked to disease progression and the largest postsurgical recurrence rate among GIST patients. Here, KIT is linked to gastrointestinal stromal tumor.